FDA ties pneumonia deaths to infant vaccine
Pharma | Toxic substances | Vaccines

MSNBC.com
Reuters
February 15, 2008

Agency panel considering approval of oral medicine for diarrhea virus

WASHINGTON - GlaxoSmithKline Plc's rotavirus vaccine is associated with increased pneumonia-related deaths and other adverse reactions, U.S. regulatory staff said in documents posted on Friday.

The review comes ahead of a Food and Drug Administration advisory meeting next Wednesday to consider approval of the oral vaccine to prevent the most common cause of severe diarrhea and dehydration among infants and young children in the world.

FDA staff said its analysis of 11 studies revealed that in the largest trial, there was a statistically significant increase in deaths related to pneumonia compared with placebo, documents posted on the FDA's Web site said.

That study, which enrolled about 63,000 children, also found an increase in convulsions in children given the drug, named Rotarix. Another study found an increased rate of bronchitis, compared with placebo.

In a conclusion section, the FDA documents noted the pneumonia-related deaths and convulsions, but did not appear to make a recommendation to the advisory panel.

That expert panel will weigh the staff review, but makes its own recommendation, which is typically followed by the FDA.

Posted by sal on February 18, 2008 11:27 AM | Comments (0)




Comment this article

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)



Similar articles

  • Iraq war veterans blame vaccine for infant deaths - Mar 02, 2004
  • Thimerosal - Top Drug Makers Face Potential Liability over Autism Linked to Infant Vaccine - Mar 18, 2004
  • Zinc 'boosts pneumonia recovery' - May 21, 2004
  • Zinc Speeds Pneumonia Recovery in Kids - May 26, 2004
  • Fluoridated Water & Infant Formula - Jun 17, 2004


    • FAIR USE NOTICE: This site may contain copyrighted (C ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available for educational purposes, to advance understanding of human rights, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in the 'fair use doctrine'. The material is distributed without profit.